4.7 Article

NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

EML4-ALK fusion lung cancer:: A rare acquired event

Sven Perner et al.

NEOPLASIA (2008)

Review Oncology

Nucleophosmin and cancer

Silvia Grisendi et al.

NATURE REVIEWS CANCER (2006)

Article Developmental Biology

Characterization of the expression of the ALK receptor tyrosine kinase in mice

E Vernersson et al.

GENE EXPRESSION PATTERNS (2006)

Article Biochemistry & Molecular Biology

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

R Chiarle et al.

NATURE MEDICINE (2005)

Article Medicine, General & Internal

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

B Falini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biochemistry & Molecular Biology

Identification of NPM-ALK interacting proteins by tandem mass spectrometry

DK Crockett et al.

ONCOGENE (2004)

Article Biochemistry & Molecular Biology

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

GE Stoica et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Biochemistry & Molecular Biology

The role of nucleophosmin in centrosome duplication

M Okuda

ONCOGENE (2002)

Article Cell Biology

Nucleophosmin regulates the stability and transcriptional activity of p53

E Colombo et al.

NATURE CELL BIOLOGY (2002)

Article Biochemistry & Molecular Biology

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

GE Stoica et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)